Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
<p>Abstract</p> <p>Background</p> <p>Despite numerous studies aimed at verifying the antitumor activity of nitric oxide-releasing nonsteroidal antiflammatory drugs (NO-NSAIDs), little is known about the molecular targets responsible for their antineoplastic properties....
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/5/1/52 |
id |
doaj-ebb321b8ad544f0f84e6b7e63a726ad4 |
---|---|
record_format |
Article |
spelling |
doaj-ebb321b8ad544f0f84e6b7e63a726ad42020-11-24T20:51:29ZengBMCJournal of Translational Medicine1479-58762007-10-01515210.1186/1479-5876-5-52Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell linesVannini IvanMedri LauraFabbri FrancescoUlivi PaolaRosetti MarcoTesei AnnaBolla ManlioAmadori DinoZoli Wainer<p>Abstract</p> <p>Background</p> <p>Despite numerous studies aimed at verifying the antitumor activity of nitric oxide-releasing nonsteroidal antiflammatory drugs (NO-NSAIDs), little is known about the molecular targets responsible for their antineoplastic properties. In the present study, we investigated the mechanisms underlying the cytotoxicity of NCX 4040, a novel NO-aspirin with promising antineoplastic action, in <it>in vitro </it>human colon cancer models.</p> <p>Methods</p> <p>The effect on tumor growth was evaluated in four human colon cancer cell lines (LoVo, LRWZ, WiDr and LoVo Dx) by sulforhodamine B assay, oxidative stress by immunohistochemistry, apoptosis by laddering assay, mitochondrial membrane potential (ΔΨ<sub>m</sub>) by flow cytometry, and apoptosis- and chemoresistance-related markers by western-blot and real-time method, respectively. Prostaglandin E<sub>2 </sub>levels were determined by ELISA.</p> <p>Results</p> <p>NCX 4040 produced a higher cytotoxic effect in all the cell lines than that produced by other NO donors tested. In particular, in LoVo and LRWZ cells, NCX 4040 induced a cytocidal effect and apoptosis through p53 and NAG-1 expression, an early ΔΨ<sub>m </sub>collapse, and a sequential release of cytoplasmatic cytochrome c and caspase -9 and -3 active forms. 8-hydroxyguanine lesions, indicative of oxidative stress, were also observed. Conversely, in WiDr line, the drug caused a cytocidal effect, albeit not through apoptosis, and a concomitant increase in COX-2 activity. In LoVo Dx line, characterized by high levels drug resistance and DNA repair-related markers, only a cytostatic effect was observed, again in concomitance with the increase in COX-2 enzyme activity.</p> <p>Conclusion</p> <p>This study highlights the multiplicity of mechanisms involved in sensitivity or resistance to NCX 4040 and could provide useful indications for tailored therapy by identifying potentially drug-responsive tumors.</p> http://www.translational-medicine.com/content/5/1/52 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vannini Ivan Medri Laura Fabbri Francesco Ulivi Paola Rosetti Marco Tesei Anna Bolla Manlio Amadori Dino Zoli Wainer |
spellingShingle |
Vannini Ivan Medri Laura Fabbri Francesco Ulivi Paola Rosetti Marco Tesei Anna Bolla Manlio Amadori Dino Zoli Wainer Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines Journal of Translational Medicine |
author_facet |
Vannini Ivan Medri Laura Fabbri Francesco Ulivi Paola Rosetti Marco Tesei Anna Bolla Manlio Amadori Dino Zoli Wainer |
author_sort |
Vannini Ivan |
title |
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines |
title_short |
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines |
title_full |
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines |
title_fullStr |
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines |
title_full_unstemmed |
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines |
title_sort |
study of molecular mechanisms of pro-apoptotic activity of ncx 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines |
publisher |
BMC |
series |
Journal of Translational Medicine |
issn |
1479-5876 |
publishDate |
2007-10-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Despite numerous studies aimed at verifying the antitumor activity of nitric oxide-releasing nonsteroidal antiflammatory drugs (NO-NSAIDs), little is known about the molecular targets responsible for their antineoplastic properties. In the present study, we investigated the mechanisms underlying the cytotoxicity of NCX 4040, a novel NO-aspirin with promising antineoplastic action, in <it>in vitro </it>human colon cancer models.</p> <p>Methods</p> <p>The effect on tumor growth was evaluated in four human colon cancer cell lines (LoVo, LRWZ, WiDr and LoVo Dx) by sulforhodamine B assay, oxidative stress by immunohistochemistry, apoptosis by laddering assay, mitochondrial membrane potential (ΔΨ<sub>m</sub>) by flow cytometry, and apoptosis- and chemoresistance-related markers by western-blot and real-time method, respectively. Prostaglandin E<sub>2 </sub>levels were determined by ELISA.</p> <p>Results</p> <p>NCX 4040 produced a higher cytotoxic effect in all the cell lines than that produced by other NO donors tested. In particular, in LoVo and LRWZ cells, NCX 4040 induced a cytocidal effect and apoptosis through p53 and NAG-1 expression, an early ΔΨ<sub>m </sub>collapse, and a sequential release of cytoplasmatic cytochrome c and caspase -9 and -3 active forms. 8-hydroxyguanine lesions, indicative of oxidative stress, were also observed. Conversely, in WiDr line, the drug caused a cytocidal effect, albeit not through apoptosis, and a concomitant increase in COX-2 activity. In LoVo Dx line, characterized by high levels drug resistance and DNA repair-related markers, only a cytostatic effect was observed, again in concomitance with the increase in COX-2 enzyme activity.</p> <p>Conclusion</p> <p>This study highlights the multiplicity of mechanisms involved in sensitivity or resistance to NCX 4040 and could provide useful indications for tailored therapy by identifying potentially drug-responsive tumors.</p> |
url |
http://www.translational-medicine.com/content/5/1/52 |
work_keys_str_mv |
AT vanniniivan studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines AT medrilaura studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines AT fabbrifrancesco studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines AT ulivipaola studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines AT rosettimarco studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines AT teseianna studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines AT bollamanlio studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines AT amadoridino studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines AT zoliwainer studyofmolecularmechanismsofproapoptoticactivityofncx4040anovelnitricoxidereleasingaspirinincoloncancercelllines |
_version_ |
1716802132887207936 |